Business
MilliporeSigma Announces Neoclease as Winner of 2025 North American Advance Biotech Grant
BURLINGTON, Mass., June 18, 2025--MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced Neoclease as the winner of the 2025 North American Advance Biotech Grant. The Boston-based biotech startup develops AI-designed gene editing therapies for Parkinson’s disease.
About this update from Merck Kgaa
[{"type":"image","alt":"Neoclease receives Millipore Sigma’s North American Advance Biotech Grant.","displaySize":"","headline":null,"caption":"Neoclease receives Millipore Sigma’s North American Advance Biotech Grant.","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":480,"url":"https://media.zenfs.com/en/business-wire.com/c769453c6f750708278e8be7e8f4a3bd"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Swc0z7P1YkMEbqQliXy4zQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTk2MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/c769453c6f750708278e8be7e8f4a3bd","width":480,"height":480}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":274,"url":"https://media.zenfs.com/en/business-wire.com/9fd2b628af08dd2f34e50802da0e4605"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/nXa8ji2QrBlmkqP1118v2g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU0ODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/9fd2b628af08dd2f34e50802da0e4605","width":480,"height":274}}},{"type":"list","items":[{"val":[{"type":"text","content":"Winner’s lead therapy targets Parkinson’s disease; platform addresses 6,000+ genetic disorders","length":94,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Neoclease gains access to MilliporeSigma’s technologies and expert support to scale its AI-designed gene-editing platform","length":121,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"The company has awarded 40+ startups globally through Advance Biotech Grant since 2014","length":86,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":301,"olType":false},{"type":"text","content":"BURLINGTON, Mass., June 18, 2025--(BUSINESS WIRE)--MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced Neoclease as the winner of the 2025 North American Advance Biotech Grant. The Boston-based biotech startup develops AI-designed gene editing therapies for Parkinson’s disease.","length":377,"tagName":"p"},{"type":"text","content":""We’re committed to empowering biotech innovators who are advancing transformative modalities like gene editing," said Sebastián Arana, Head of Pr...